Review





Similar Products

99
ATCC hepg2 human liver cancer cells
Hepg2 Human Liver Cancer Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hepg2+cells/Hep+G2/pm43018616-284-42-53
Average 99 stars, based on 1 article reviews
hepg2 human liver cancer cells - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

96
ATCC human hepatocellular carcinoma hepg2 c3a cells
Human Hepatocellular Carcinoma Hepg2 C3a Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hepg2+cells/C3A/pmc13753295-25-13-27
Average 96 stars, based on 1 article reviews
human hepatocellular carcinoma hepg2 c3a cells - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

99
ATCC hepg2 human hepatocellular carcinoma cells
Hepg2 Human Hepatocellular Carcinoma Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hepg2+cells/Hep+G2/pmc13745806-86-0-13
Average 99 stars, based on 1 article reviews
hepg2 human hepatocellular carcinoma cells - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC human hepatocellular carcinoma cell line hepg2
Human Hepatocellular Carcinoma Cell Line Hepg2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hepg2+cells/Hep+G2/10__1161_slash_jaha__126__055499-62-1-9
Average 99 stars, based on 1 article reviews
human hepatocellular carcinoma cell line hepg2 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC hepg2 cell growth
Hepg2 Cell Growth, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hepg2+cells/Hep+G2/pm42982185-293-0-9
Average 99 stars, based on 1 article reviews
hepg2 cell growth - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC hepg2 cells
Hepg2 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hepg2+cells/Hep+G2/pm42982175-157-0-2
Average 99 stars, based on 1 article reviews
hepg2 cells - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC hepg2 human hepatic cancer cells
Hepg2 Human Hepatic Cancer Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hepg2+cells/Hep+G2/pmc13762198-38-15-42
Average 99 stars, based on 1 article reviews
hepg2 human hepatic cancer cells - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
ATCC human liver hepatocellular carcinoma cell line hepg2 cell line
Bulk RNA-seq data from <t>TCGA-LIHC</t> and GTEx were analysed to assess KNL1 expression, its association with TP53 mutation status, and correlation with chromosomal instability metrics, including tumor mutation burden (TMB), tumor break load (TBL), fraction genome altered (FGA) and aneuploidy score. Step 2: WGCNA identified a KNL1-associated gene module, which underwent functional enrichment via MSigDB hallmark gene sets and STRING protein–protein interaction network analysis . Step 3: Hub genes from this module were used to compute a KNL1-associated G2/M network score that was used to stratify tumors into high and low score groups for chromosomal instability (TBL, TMB, FGA and aneuploidy score), proliferation (MKI67 expression), survival, immune infiltration (CIBERSORTx) and immune evasion (TIDE scoring) analyses. Step 4: Single-cell RNA-seq data from GSE149614 were used to examine cell type–specific expression, cell cycle phase distribution, and cell–cell communication patterns of the KNL1-associated G2M module. Finally, functional validation was performed in vitro using CRISPR-Cas9-mediated downregulation of KNL1 in <t>HepG2</t> cells, followed by assays for proliferation, cell cycle arrest, and ultrastructural evaluation by transmission electron microscopy (TEM). Box color codes: Light blue – Bulk RNA-seq analysis steps; Dark blue – Single-cell RNA-seq analysis; Grey – In vitro validation. [RNA-seq, RNA sequencing; TCGA-LIHC, The Cancer Genome Atlas Liver <t>Hepatocellular</t> <t>Carcinoma;</t> GTEx, Genotype-Tissue Expression; KNL1, Kinetochore Scaffold 1; TP53, tumor protein p53; CIN, chromosomal instability; WGCNA, Weighted Gene Co-expression Network Analysis; MSigDB, Molecular Signatures Database; STRING, Search Tool for the Retrieval of Interacting Genes/Proteins; MKI67, marker of proliferation Ki-67; CIBERSORTx, Cell-type Identification By Estimating Relative Subsets Of RNA Transcripts; TIDE, Tumor Immune Dysfunction and Exclusion; CRISPR, Clustered Regularly Interspaced Short Palindromic Repeats; Cas9, CRISPR-associated protein 9; TEM, transmission electron microscopy].
Human Liver Hepatocellular Carcinoma Cell Line Hepg2 Cell Line, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hepg2+cells/Hep+G2/bio_rxiv__64898__2026__10__31__763338-149-0-17
Average 99 stars, based on 1 article reviews
human liver hepatocellular carcinoma cell line hepg2 cell line - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

Image Search Results


Bulk RNA-seq data from TCGA-LIHC and GTEx were analysed to assess KNL1 expression, its association with TP53 mutation status, and correlation with chromosomal instability metrics, including tumor mutation burden (TMB), tumor break load (TBL), fraction genome altered (FGA) and aneuploidy score. Step 2: WGCNA identified a KNL1-associated gene module, which underwent functional enrichment via MSigDB hallmark gene sets and STRING protein–protein interaction network analysis . Step 3: Hub genes from this module were used to compute a KNL1-associated G2/M network score that was used to stratify tumors into high and low score groups for chromosomal instability (TBL, TMB, FGA and aneuploidy score), proliferation (MKI67 expression), survival, immune infiltration (CIBERSORTx) and immune evasion (TIDE scoring) analyses. Step 4: Single-cell RNA-seq data from GSE149614 were used to examine cell type–specific expression, cell cycle phase distribution, and cell–cell communication patterns of the KNL1-associated G2M module. Finally, functional validation was performed in vitro using CRISPR-Cas9-mediated downregulation of KNL1 in HepG2 cells, followed by assays for proliferation, cell cycle arrest, and ultrastructural evaluation by transmission electron microscopy (TEM). Box color codes: Light blue – Bulk RNA-seq analysis steps; Dark blue – Single-cell RNA-seq analysis; Grey – In vitro validation. [RNA-seq, RNA sequencing; TCGA-LIHC, The Cancer Genome Atlas Liver Hepatocellular Carcinoma; GTEx, Genotype-Tissue Expression; KNL1, Kinetochore Scaffold 1; TP53, tumor protein p53; CIN, chromosomal instability; WGCNA, Weighted Gene Co-expression Network Analysis; MSigDB, Molecular Signatures Database; STRING, Search Tool for the Retrieval of Interacting Genes/Proteins; MKI67, marker of proliferation Ki-67; CIBERSORTx, Cell-type Identification By Estimating Relative Subsets Of RNA Transcripts; TIDE, Tumor Immune Dysfunction and Exclusion; CRISPR, Clustered Regularly Interspaced Short Palindromic Repeats; Cas9, CRISPR-associated protein 9; TEM, transmission electron microscopy].

Journal: bioRxiv

Article Title: Uncovering the Multifaceted Role of the Kinetochore Scaffold 1 (KNL1) in Hepatocellular Carcinoma: Integrative Bioinformatics Analysis and CRISPR-Cas9 Experimental Study

doi: 10.64898/2026.10.31.763338

Figure Lengend Snippet: Bulk RNA-seq data from TCGA-LIHC and GTEx were analysed to assess KNL1 expression, its association with TP53 mutation status, and correlation with chromosomal instability metrics, including tumor mutation burden (TMB), tumor break load (TBL), fraction genome altered (FGA) and aneuploidy score. Step 2: WGCNA identified a KNL1-associated gene module, which underwent functional enrichment via MSigDB hallmark gene sets and STRING protein–protein interaction network analysis . Step 3: Hub genes from this module were used to compute a KNL1-associated G2/M network score that was used to stratify tumors into high and low score groups for chromosomal instability (TBL, TMB, FGA and aneuploidy score), proliferation (MKI67 expression), survival, immune infiltration (CIBERSORTx) and immune evasion (TIDE scoring) analyses. Step 4: Single-cell RNA-seq data from GSE149614 were used to examine cell type–specific expression, cell cycle phase distribution, and cell–cell communication patterns of the KNL1-associated G2M module. Finally, functional validation was performed in vitro using CRISPR-Cas9-mediated downregulation of KNL1 in HepG2 cells, followed by assays for proliferation, cell cycle arrest, and ultrastructural evaluation by transmission electron microscopy (TEM). Box color codes: Light blue – Bulk RNA-seq analysis steps; Dark blue – Single-cell RNA-seq analysis; Grey – In vitro validation. [RNA-seq, RNA sequencing; TCGA-LIHC, The Cancer Genome Atlas Liver Hepatocellular Carcinoma; GTEx, Genotype-Tissue Expression; KNL1, Kinetochore Scaffold 1; TP53, tumor protein p53; CIN, chromosomal instability; WGCNA, Weighted Gene Co-expression Network Analysis; MSigDB, Molecular Signatures Database; STRING, Search Tool for the Retrieval of Interacting Genes/Proteins; MKI67, marker of proliferation Ki-67; CIBERSORTx, Cell-type Identification By Estimating Relative Subsets Of RNA Transcripts; TIDE, Tumor Immune Dysfunction and Exclusion; CRISPR, Clustered Regularly Interspaced Short Palindromic Repeats; Cas9, CRISPR-associated protein 9; TEM, transmission electron microscopy].

Article Snippet: Human liver hepatocellular carcinoma cell line (HepG2) cell line used in this work was obtained from the American Type Culture Collection (ATCC) ( https://www.atcc.org/ ).

Techniques: RNA Sequencing, Expressing, Mutagenesis, Functional Assay, Analysis, Single Cell, Biomarker Discovery, In Vitro, CRISPR, Transmission Assay, Electron Microscopy, Tissue, Marker, Reverse Transcription Polymerase Chain Reaction